[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.169.168. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
November 1982

Ocular Chrysiasis

Author Affiliations

From the Eye Pathology Laboratory of the Wilmer Ophthalmological Institute and the Department of Pathology, The John Hopkins Medical Institutions, Baltimore.

Arch Ophthalmol. 1982;100(11):1791-1794. doi:10.1001/archopht.1982.01030040771012
Abstract

• Gold deposits were seen in the cornea and conjunctiva of a 71-year-old woman after therapy with 5.5 g of gold sodium thiomalate. We were able to demonstrate gold deposition both histopathologically and ultrastructurally in a conjunctival biopsy specimen. Gold deposition is usually benign and does not require cessation of therapy unless inflammatory complications occur.

References
1.
Finkelstein AE, Roisman FR, Batista V, et al:  Oral chrysotherapy in rheumatoid arthritis: Minimum effective dose . J Rheumatol 1980;7:160-168.
2.
Bonnet P, Bonamour G, El Khalifah M:  La chryseose de l'oeil . Arch Ophtalmol 1939;3:385-394.
3.
Rodenhauser JH:  Über Augenveränderungen nach parenteraler Goldbehandlung . Klin Monatsbl Augenheilkd 1969;155:61-65.
4.
Roberts WH, Wolter JR:  Ocular chrysiasis . Arch Ophthalmol 1956;56:48-52.Article
5.
Hashimoto A, Maeda Y, Ito H, et al:  Corneal chrysiasis: A clinical study in rheumatoid arthritis patients receiving gold therapy . Arthritis Rheum 1972;15:309-312.Article
6.
Duke-Elder S, MacFaul PA: System of Ophthalmology . St Louis, CV Mosby Co, 1972, vol 14, p 1246.
7.
Grant WM: Toxicology of the Eye , ed 2. Springfield, Ill, Charles C Thomas Publisher, 1974, pp 530-533.
8.
Watanabe I, Whittier FC Jr, Moore J, et al:  Gold nephropathy: Ultrastructural, fluorescence, and microanalytic studies of two patients . Arch Pathol Lab Med 1976;100:632-635.
9.
Gilman AG, Goodman LS, Gilman A (eds): Goodman and Gilman's The Pharmacological Basis of Therapeutics , ed 6. New York, Macmillan Publishing Co Inc, 1980, pp 713-717.
10.
Gottlieb NL, Major JC:  Ocular chrysiasis correlated with gold concentrations in the crystalline lens during chrysotherapy . Arthritis Rheum 1978;21:704-708.Article
11.
Edmund C:  Reactions of normal eyes in patients treated with sanocrysin . Acta Ophthalmol 1927;4:237-261.Article
12.
Walsh FB: Clinical Neuro-ophthalmology , ed 1. Baltimore, Williams & Wilkins Co, 1957, pp 1211-1212.
13.
Fishman RS, Sunderman FW:  Band keratopathy in gout . Arch Ophthalmol 1966;75:367-369.Article
14.
Sanderson PO, Kuwabara T, Stark WJ, et al:  Cystinosis: A clinical, histopathologic, and ultrastructural study . Arch Ophthalmol 1974;91:270-274.Article
15.
Davidson A:  Primary lipid dystrophy of the cornea . Arch Ophthalmol 1947;37:433-443.Article
16.
Miller KH, Green WR, Stark WJ, et al:  Immunoprotein deposition in the cornea . Ophthalmology 1980;87:944-950.Article
17.
Duke-Elder S:  Diseases of the outer eye: II. Cornea and sclera , in Duke-Elder S (ed): System of Ophthalmology . St Louis, CV Mosby Co, 1965, vol 8, pp 945-946.
18.
Bagolini B, Ioli-Spada G:  Bietti's tapetoretinal degeneration with marginal corneal dystrophy . Am J Ophthalmol 1968;65:53-60.
×